KNBIF (Kane Biotech) Total Assets: $1.32 Mil (As of Mar. 2026)


What is Kane Biotech Total Assets?

Kane Biotech KNBIF +5.19% Total Assets is $1.32 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Kane Biotech's Total Assets for the quarter that ended in Mar. 2026 was $1.32 Mil.

During the past 12 months, Kane Biotech's average Total Assets Growth Rate was -37.40% per year. During the past 3 years, the average Total Assets Growth Rate was -26.00% per year. During the past 5 years, the average Total Assets Growth Rate was -16.70% per year. During the past 10 years, the average Total Assets Growth Rate was 10.90% per year.

During the past 13 years, Kane Biotech's highest 3-Year average Total Assets Growth Rate was 64.00%. The lowest was -26.00%. And the median was 7.80%.

Total Assets is connected with ROA %. Kane Biotech's annualized ROA % for the quarter that ended in Mar. 2026 was -126.23%. Total Assets is also linked to Revenue through Asset Turnover. Kane Biotech's Asset Turnover for the quarter that ended in Mar. 2026 was 0.02.

Kane Biotech  (OTCPK:KNBIF) Total Assets Explanation

Total Assets is connected with ROA %.

Kane Biotech's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-2.084/( (1.982+1.32)/ 2 )
=-2.084/1.651
=-126.23 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Kane Biotech's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0.031/( (1.982+1.32)/ 2 )
=0.031/1.651
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Kane Biotech Total Assets Related Terms

Kane Biotech Total Assets Historical Data

* Premium members only.

The historical data trend for Kane Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Total Assets Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.79 4.14 4.23 1.75 1.98

Kane Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.92 2.79 1.98 1.98 1.32

Kane Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Kane Biotech's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=-0.542+2.523
=1.98

Kane Biotech's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=-1.034+2.353
=1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $1.32 Mil mean?
Kane Biotech (KNBIF) has a Total Assets of $1.32 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Kane Biotech and its competitors.
Is Kane Biotech's Total Assets too high?
Kane Biotech's current Total Assets is $1.32 Mil.
How does Kane Biotech's Total Assets compare to VRTX and REGN?
Kane Biotech's Total Assets of $1.32 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Kane Biotech and its competitors. Kane Biotech's current Total Assets is $1.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current Total Assets of $1.32 Mil. The current Total Assets is $1.32 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current Total Assets is $1.32 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.